Last month, Mark Zuckerberg, Meta’s CEO, boldly came out in support of “open source” artificial intelligence models that are publicly available to download and modify without payment or approval. The way forward, he said, was through “openness and putting the power of tech into more people’s hands, not fewer.” On Monday, Zuckerberg doubled down on […]
Patients who need to lower their cholesterol will soon have a powerful new option. The Food and Drug Administration recently approved a new pill called enlicitide that can lower cholesterol levels substantially more than statins alone. The drug, which was developed by Merck and will be sold under the brand name Lipfendra, is expected to […]
To stay in the top job, a British prime minister has to try and keep certain groups happy. MPs, party members and donors do not like to be ignored. Nor do the bond markets. And often it feels like they matter the most. That’s because those markets are what make it possible for governments to […]
